I had the experience of flagyl usage once but this case left in my thought for a long time. where to buy Flagyl ? Colchicine may be contraindicated for patients who are diagnosed affections of the gastrointestinal tract, bone marrow, hypogranulocytosis, dysfunction of liver and kidney.

Accountor announces investment by Vitruvian Partners to support its future growth

Accountor Holding Oy (“Accountor”), the leading provider of financial, accounting and HR solutions in Northern Europe, today announced a significant investment by funds managed and advised by Vitruvian Partners (“Vitruvian”), subject only to customary regulatory approvals. As part of the transaction, Founder and Chief Executive Officer Asko Schrey will retain a significant stake in the company, while Vitruvian becomes the new majority owner. Several current shareholders, including funds managed by Sponsor Capital, will reinvest.The new ownership will enable Accountor to continue to invest in its people, processes and industry-leading technology in order to build upon its premier position in a large and rapidly growing market.

Asko Schrey, Founder and Chief Executive Officer of Accountor, commented:
“Accountor is playing a market leading role in the evolution of the Nordic landscape for financial and accounting services, enhancing the way in which clients operate and enabling their continued profitable growth and success. Having started off as a single accounting office in Finland in 1987, Accountor today operates more than 140 offices across seven countries and provides some of the industry’s most innovative solutions to over 30,000 customers. Over the past 15 years, we have grown our revenues from less than €3 million to over €200 million, through a combination of M&A and rapid organic growth, particularly driven by innovation in our software division. This progress would not have been possible without the dedication of our people and loyal customers, as well as our current investors. Vitruvian has a strong track record in supporting fast-growing companies in their international and product expansion efforts, as well as an unrivalled experience within the software space. In combination with the ambition to support a continued acquisition strategy, this makes Vitruvian the perfect partner for the next stage of Accountor’s growth.”

Mike Risman, Managing Partner at Vitruvian Partners, added:
“Vitruvian is excited to invest in Accountor at a time when the financial and accounting outsourcing market is undergoing rapid digitisation. Our investment will allow the company the flexibility to accelerate its growth both organically and inorganically by further leveraging its unique proposition of combining market leading software products with a vital layer of direct customer contact through its pan-Nordic office network. Asko and his team have created a truly outstanding market leader in growing Accountor to its current size, and we are delighted to partner with them to jointly drive the next phase of the company’s development.”

Juhani Kalliovaara, Partner at Sponsor Capital, added:
“For Sponsor Capital it has been an exciting journey to share in the growth of Accountor during the past six years. In our view, Accountor is a textbook example of a great Finnish champion becoming an international and Nordic success story and we are proud to have worked alongside Asko and his team throughout this phase. Our sizeable reinvestment into the business is a sign of our trust in the future of this exciting enterprise and we look forward to our continued partnership in the next years.

For further information on Accountor, please visit http://www.accountorgroup.com